It is disclosed a method for treating hepatitis B virus infection or hepatitis B virus/hepatits delta virus co-infection, the method comprising administering to a subject in need of such treatment a first pharmaceutically acceptable agent that comprises at least one phosphorothioated nucleic acid polymer and a second pharmaceutically acceptable agent that comprises at least one nucleoside/nucleotide analog HBV polymerase inhibitor.
揭示了一种治疗乙型肝炎病毒感染或乙型肝炎病毒/丁型肝炎病毒共感染的方法,该方法包括向需要此类治疗的受试者施用至少包含一种
磷硫酸酯核酸聚合物的第一种药用可接受剂和至少包含一种核苷/核苷酸类似物HBV聚合酶
抑制剂的第二种药用可接受剂。